Articular Cartilage Injury; Current Status and Future Direction.

IF 2.1 4区 医学 Q4 CELL & TISSUE ENGINEERING
Maryam Moradi, Farzad Parvizpour, Zohreh Arabpour, Nikan Zargarzadeh, Mahnaz Nazari, Heewa Rashnavadi, Farshid Sefat, Sanaz Dehghani, Marzieh Latifi, Arefeh Jafarian
{"title":"Articular Cartilage Injury; Current Status and Future Direction.","authors":"Maryam Moradi, Farzad Parvizpour, Zohreh Arabpour, Nikan Zargarzadeh, Mahnaz Nazari, Heewa Rashnavadi, Farshid Sefat, Sanaz Dehghani, Marzieh Latifi, Arefeh Jafarian","doi":"10.2174/1574888X18666230418121122","DOIUrl":null,"url":null,"abstract":"<p><p>Today, treatments of cartilage and osteochondral lesions are routine clinical procedures. The avascular and hard-to-self-repair nature of cartilage tissue has posed a clinical challenge for the replacement and reconstruction of damaged cartilage. Treatment of large articular cartilage defects is technically difficult and complex, often accompanied by failure. Articular cartilage cannot repair itself after injury due to a lack of blood vessels, lymph, and nerves. Various treatments for cartilage regeneration have shown encouraging results, but unfortunately, none have been the perfect solution. New minimally invasive and effective techniques are being developed. The development of tissue engineering technology has created hope for articular cartilage reconstruction. This technology mainly supplies stem cells with various sources of pluripotent and mesenchymal stem cells. This article describes the treatments in detail, including types, grades of cartilage lesions, and immune mechanisms in cartilage injuries.</p>","PeriodicalId":10979,"journal":{"name":"Current stem cell research & therapy","volume":" ","pages":"653-661"},"PeriodicalIF":2.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current stem cell research & therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1574888X18666230418121122","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Today, treatments of cartilage and osteochondral lesions are routine clinical procedures. The avascular and hard-to-self-repair nature of cartilage tissue has posed a clinical challenge for the replacement and reconstruction of damaged cartilage. Treatment of large articular cartilage defects is technically difficult and complex, often accompanied by failure. Articular cartilage cannot repair itself after injury due to a lack of blood vessels, lymph, and nerves. Various treatments for cartilage regeneration have shown encouraging results, but unfortunately, none have been the perfect solution. New minimally invasive and effective techniques are being developed. The development of tissue engineering technology has created hope for articular cartilage reconstruction. This technology mainly supplies stem cells with various sources of pluripotent and mesenchymal stem cells. This article describes the treatments in detail, including types, grades of cartilage lesions, and immune mechanisms in cartilage injuries.

关节软骨损伤;现状与未来方向。
如今,治疗软骨和骨软骨损伤已成为常规临床程序。软骨组织具有无血管和难以自我修复的特性,这给替换和重建受损软骨带来了临床挑战。大面积关节软骨缺损的治疗技术难度高且复杂,往往伴随着失败。由于缺乏血管、淋巴和神经,关节软骨在损伤后无法自我修复。各种软骨再生治疗方法都取得了令人鼓舞的效果,但遗憾的是,没有一种是完美的解决方案。目前正在开发新的微创有效技术。组织工程技术的发展为关节软骨重建带来了希望。这种技术主要提供干细胞,有多能干细胞和间充质干细胞等多种来源。本文详细介绍了软骨损伤的治疗方法,包括软骨损伤的类型、等级和免疫机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current stem cell research & therapy
Current stem cell research & therapy CELL & TISSUE ENGINEERING-CELL BIOLOGY
CiteScore
4.20
自引率
3.70%
发文量
197
审稿时长
>12 weeks
期刊介绍: Current Stem Cell Research & Therapy publishes high quality frontier reviews, drug clinical trial studies and guest edited issues on all aspects of basic research on stem cells and their uses in clinical therapy. The journal is essential reading for all researchers and clinicians involved in stem cells research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信